Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer
Open Access
- 15 June 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (2), 223-231
- https://doi.org/10.1038/sj.bjc.6605734
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Critical dependence of blood-borne biomarker concentrations on the half-lives of their carrier proteinsJournal of Theoretical Biology, 2008
- Enrichment of Phosphopeptides Using Biphasic Immobilized Metal Affinity-Reversed Phase MicrocolumnsJournal of Proteome Research, 2008
- Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cellsOncogene, 2007
- In ReplyJournal of Clinical Oncology, 2007
- Automated serum peptide profilingNature Protocols, 2006
- New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From PancreatitisJournal of Clinical Oncology, 2006
- Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic CancerClinical Cancer Research, 2006
- Molecular Markers of Early Pancreatic CancerJournal of Clinical Oncology, 2005
- Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination TherapyJournal of Clinical Oncology, 2005
- Exploring the Host Desmoplastic Response to Pancreatic CarcinomaThe American Journal of Pathology, 2002